Johnson Pharmacare Limited has issued a prior intimation to BSE Limited regarding an upcoming board meeting, pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
The Board of Directors meeting is scheduled to be held on Thursday, 13th August, 2026 at the company's registered office at Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium, Navrangpura, Ahmedabad City, Gujarat-380009.
The primary agenda for the meeting is:
- To consider and approve the Un-Audited (Standalone) Financial Results of the Company for the quarter ended on 30th June, 2026.
The company also disclosed that the Trading Window has been closed since 1st July, 2026 and will remain closed until the completion of 48 hours after the declaration of the unaudited (Standalone) Financial Results for the quarter ended 30th June, 2026.
The board may consider any other agenda items with the prior permission of the Chairperson.